Intracellular tracing of amyloid vaccines through direct fluorescent labelling
Abstract Alzheimer’s disease is a debilitating neurodegenerative condition that progressively causes synaptic loss and major neuronal damage. Immunotherapy utilising Aβ as an active immunogen or via passive treatment utilising antibodies raised to amyloid have shown therapeutic promise. The migrator...
Guardado en:
Autores principales: | Matthew Mold, Manpreet Kumar, Ambreen Mirza, Emma Shardlow, Christopher Exley |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b074227a314421a9bdb4071a5bde60f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multimodal, label-free fluorescence and Raman imaging of amyloid deposits in snap-frozen Alzheimer’s disease human brain tissue
por: Benjamin Lochocki, et al.
Publicado: (2021) -
Solvation-Guided Design of Fluorescent Probes for Discrimination of Amyloids
por: Kevin J. Cao, et al.
Publicado: (2018) -
Label-free X-ray estimation of brain amyloid burden
por: Eshan Dahal, et al.
Publicado: (2020) -
Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide
por: Tomonori Tamura, et al.
Publicado: (2018) -
Improved split fluorescent proteins for endogenous protein labeling
por: Siyu Feng, et al.
Publicado: (2017)